Sandro Wealth Management LLC Takes Position in HCA Healthcare, Inc. $HCA

Sandro Wealth Management LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 6,627 shares of the company’s stock, valued at approximately $2,584,000. HCA Healthcare comprises approximately 1.9% of Sandro Wealth Management LLC’s portfolio, making the stock its 18th biggest holding.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Nomura Asset Management Co. Ltd. raised its stake in shares of HCA Healthcare by 6.2% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after acquiring an additional 3,724 shares during the last quarter. Advisors Capital Management LLC increased its holdings in HCA Healthcare by 61.5% during the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after purchasing an additional 2,604 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in HCA Healthcare by 11.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares during the period. Liberty Wealth Management LLC purchased a new position in shares of HCA Healthcare during the fourth quarter valued at approximately $1,905,000. Finally, Sunbelt Securities Inc. lifted its stake in HCA Healthcare by 171.7% in the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after acquiring an additional 3,945 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $404.61 on Friday. The firm has a 50-day simple moving average of $393.41 and a two-hundred day simple moving average of $446.80. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The firm has a market cap of $87.60 billion, a P/E ratio of 13.55, a P/E/G ratio of 1.40 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the firm earned $6.84 earnings per share. On average, equities research analysts predict that HCA Healthcare, Inc. will post 29.47 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.45%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Oppenheimer cut their target price on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research note on Monday, July 27th. UBS Group cut their price objective on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Cantor Fitzgerald lowered their target price on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research note on Tuesday, July 7th. The Goldman Sachs Group reduced their price target on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research note on Tuesday, July 28th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $465.59.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.